TRIAL IN PROGRESS: AN OPEN-LABEL, PHASE 2 STUDY TO EVALUATE EFFICACY, SAFETY, PK, PD OF KP104, A BIFUNCTIONAL COMPLEMENT INHIBITOR, IN IGAN AND C3G SUBJECTS
Back
Abstract Number
WCN23-1154
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Chronic Kidney Disease Diagnosis, Classification and Progression
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
TRIAL IN PROGRESS: AN OPEN-LABEL, PHASE 2 STUDY TO EVALUATE EFFICACY, SAFETY, PK, PD OF KP104, A BIFUNCTIONAL COMPLEMENT INHIBITOR, IN IGAN AND C3G SUBJECTS
Co-authors
Lv, J.(1);Zhang, H.(1);Pedagogos, E.(2);Ma, J.(3);Zhou, H.(3);Rabe, M.(3);Hart, A.(4);Yue, C.(5);Yan, A.(5);Tsui, P.(3);Wu, J.(3);Fu, H.(3);Lee, R.(3);Wang, C.(5)*;
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Peking University First Hospital, Nephrology Department, Beijing, China;(2)Western Health, Department Of Nephrology, Melbourne, Australia;(3)Kira Pharmaceuticals- Us, Research And Development, Cambridge- Ma, United States;(4)Kira Pharmaceuticals- Au, Research And Development, Gold Coast, Australia;(5)Kira Pharmaceuticals Suzhou Limited- China, Research And Development, Suzhou, China;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/c9ada65324bd47ca254040016960bb0b.pdf
Audio File
if any